Genr8 within

Genr8 within is an evidence-based company providing next-generation treatments for orthopedic defects, chronic wounds, nerve, ligament and tendon repair. Genr8 within believes in developing transparent, long-term professional and personal relationships with physicians and our sales partners. Our goal is to deliver safe, effective, innovative solutions to improve outcomes for our number one priority, the patient.

Amnion Derived Human Allografts

During human pregnancy the inner most lining of the placenta (amnion) encapsulates the fetus, filling with amniotic fluid. The unique structure of the human amnion and amniotic fluid provide a protective environment abundant with essential nutrients, proteins, growth factors, and stem cells for the developing embryo throughout the pregnancy. With the family's consent, these otherwise discarded tissues can be donated for medical use and provide life changing treatments for others in need.

Clinicians have used amniotic tissue for over a century as a biologic dressing in a broad range of therapeutic applications. It has been generally recognized as an effective modality in advancing treatment of soft tissue defects, soft tissue trauma, tendonitis, tendonosis, chronic wounds, and localized inflammation. Characteristics unique to amniotic tissue and fluid make these biological structures an extremely safe and effective option for number of treatments.

  • Anti-Inflammatory
  • Anti-Microbial
  • Anti-Fibrotic
  • Nutrient-Rich
  • Immune Privileged*

Amnion-derived products harness the human body's natural potential to regenerate tissue and return to a pre-wound state. Physicians have applied amniotic membrane products to facilitate proper healing in chronic cutaneous wounds, including diabetic, venous, arterial and decubitus ulcers with incredible success, enabling closure of even the most difficult to treat chronic wounds.

Physicians and Scientists alike continue their efforts to unlock the amazing regenerative potential of the human amnion and amniotic fluid in more and more modern-day treatments. Currently, amnion-derived products have proven their value to focus the human body's natural ability to regenerate at point of injury, and have shown promise in the future treatment of Parkinson's disease and cancer.

*Amniotic membrane & fluid has low risk of immunogenicity; class II antigens are not expressed